BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12153184)

  • 1. Pediatric acute blastic natural killer cell leukemia.
    DuBois SG; Etzell JE; Matthay KK; Robbins E; Banerjee A
    Leuk Lymphoma; 2002 Apr; 43(4):901-6. PubMed ID: 12153184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study.
    DiGiuseppe JA; Louie DC; Williams JE; Miller DT; Griffin CA; Mann RB; Borowitz MJ
    Am J Surg Pathol; 1997 Oct; 21(10):1223-30. PubMed ID: 9331296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell precursor acute lymphoma/leukemia presenting in an infant.
    Natkunam Y; Cherry AM; Cornbleet PJ
    Arch Pathol Lab Med; 2001 Mar; 125(3):413-8. PubMed ID: 11231495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncommon cases of immature-type CD56+ natural killer (NK)-cell neoplasms, characterized by expression of myeloid antigen of blastic NK-cell lymphoma.
    Owatari S; Otsuka M; Takeshita T; Mizukami K; Suzuki S; Uozumi K; Tashiro Y; Arima N; Hanada S
    Int J Hematol; 2009 Mar; 89(2):188-194. PubMed ID: 19109730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blastic natural killer cell leukemia--one case report and review of literature].
    Guo XN; Wang CY; Wang Y; Xu SR; Ren JH; Lin FR; Yao EG
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):362-4. PubMed ID: 12941191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic natural killer cell lymphoma/leukemia: a report of seven cases.
    Bayerl MG; Rakozy CK; Mohamed AN; Vo TD; Long M; Eilender D; Palutke M
    Am J Clin Pathol; 2002 Jan; 117(1):41-50. PubMed ID: 11789729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
    Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of the art in natural killer cell malignancies.
    Semenzato G; Marino F; Zambello R
    Int J Lab Hematol; 2012 Apr; 34(2):117-28. PubMed ID: 21895989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
    Sun T; Pashaei S; Jaffrey I; Ryder J
    Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of natural killer cell leukemia misdiagnosed as tuberculous lymphadenopathy.
    Lee AJ; Kim SG; Jeon CH; Suh HS; Yoon GS; Seo AN
    Korean J Lab Med; 2009 Jun; 29(3):194-8. PubMed ID: 19571615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemia of natural killer cell large granular lymphocyte type with HLA-DR-CD16-CD56bright+ phenotype.
    Prieto J; Ríos E; Parrado A; Martín A; de Blas JM; Rodríguez JM
    J Clin Pathol; 1996 Dec; 49(12):1011-3. PubMed ID: 9038741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in understanding and managing natural killer-cell malignancies.
    Oshimi K
    Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity.
    Falcão RP; Garcia AB; Marques MG; Simões BP; Fonseca BA; Rodrigues ML; Foss NT
    Leuk Res; 2002 Sep; 26(9):803-7. PubMed ID: 12127554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
    Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
    Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.
    Suzuki R; Suzumiya J; Nakamura S; Aoki S; Notoya A; Ozaki S; Gondo H; Hino N; Mori H; Sugimori H; Kawa K; Oshimi K;
    Leukemia; 2004 Apr; 18(4):763-70. PubMed ID: 14961041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.